2024
Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure
Kyanko K, Sahay K, Wang Y, Li S, Schreiber M, Hager M, Myers R, Johnson W, Zhang J, Krumholz H, Suter L, Triche E. Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure. JAMA Network Open 2024, 7: e2414431. PMID: 38829614, PMCID: PMC11148674, DOI: 10.1001/jamanetworkopen.2024.14431.Peer-Reviewed Original ResearchConceptsCenters for Medicare & Medicaid ServicesSpecialty subgroupsPerformance quintileMedicare AdvantageReadmission ratesRisk-standardized readmission ratesHospital-wide readmission measureHospital outcome measuresTest-retest reliabilityRisk-adjustment variablesMeasurement reliabilityAdministrative claims dataReadmission measuresImprove measurement reliabilityIntegrated data repositoryMA beneficiariesQuintile rankingsMedicare beneficiariesMedicaid ServicesAll-causePublic reportingStudy assessed differencesClaims dataOutcome measuresMA cohort
2018
A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017
Sahay KM, Smith T, Conway KM, Romitti PA, Lamb MM, Andrews J, Pandya S, Oleszek J, Cunniff C, Valdez R. A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017. Journal Of Child Neurology 2018, 34: 44-53. PMID: 30345857, PMCID: PMC6444919, DOI: 10.1177/0883073818801704.Peer-Reviewed Original ResearchConceptsDiagnostic delayRare disorderFirst population-based prevalence estimatesPopulation-based prevalence estimatesMedical record abstractionPopulation-based surveillanceHealth service useMuscular Dystrophy SurveillanceHealth care outcomesChildhood-onset dystrophinopathyRecord abstractionCare outcomesService usePeer-reviewed publicationsGrowth chartsPrevalence estimatesBecker muscular dystrophyDisease controlAdditional publicationsDiagnostic outcomesMuscular dystrophyPopulation studiesDystrophinopathiesResearch NetworkDisorders